Our 3rd Annual Molecular Diagnostics Virtual Conference is now available On Demand! The Molecular Diagnostics Event is the premiere venue for scientists, technologists, and professionals to discuss and present the newest advances in molecular diagnostics testing.
Learn from keynote speaker and renown expert Dr. Eunice Lee, Branch Chief of Molecular Pathology and Cytology Branch with the FDA, and other experts like Dr. Steven Lee of University of California, Berkeley; Dr. Judd Moul from Duke University Medical Center; and Dr. Jason Kralj from NIST. Enjoy the complementary conference from your desk with no need for travel, and explore the virtual exhibit hall to learn about the latest technologies and techniques for your lab.
Topics in the 2018 event included:
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.
Produced on a new, more robust platform, you can watch, learn and connect during this conference on mobile devices easier than ever before. Equipped with a leaderboard and scavengerhunt, you can now move around the entire event earning points for a chance to win one of LabRoots most popular shirts
Use #LRmoldx to follow the conversation!
DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics.
Delivering a better way to improve patient outcomes by enabling access to molecular diagnostic testing everywhere.
Illumina is transforming human health as the global leader in sequencing and array-based technologies. Illumina's flexible and scalable sequencing systems support and enable a wide range of single-cell sequencing applications, from low-throughput deep interrogation of rare cell ...See more See less
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
For over 25 years, Aurora Biomed has been a global leader in the design and development of lab automation solutions for life science, environmental science, drug discovery/safety and chemical analysis research. We are committed to improving the quality of human and environmental ...See more See less
Bentham Science has three main operating divisions: subscription-based journals, open access titles, and e-books. We publish research literature in all areas of science, medicine, technology, humanities, and social sciences, which is available in both electronic and print ...See more See less
Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...See more See less
Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...See more See less
Dr. Emily Hollister is a microbial ecologist and serves as the Vice President for Information Technology & Analytics at Diversigen, Inc. Prior to joining Diversigen, Dr. Hollister served as an Assistant Professor in the Department of Pathology & Immunology at Baylor College of ...See more See less
The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...See more See less
Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...See more See less